3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Withdrawn
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Classical hematology
1
Conditions
Hematologic Neoplasms
3
Pseudomonas Infections
1
Pneumonia
1
Neutropenia
1
Gram-Negative Bacterial Infections
1
Febrile Neutropenia
1
Bacteremia
1
Interventions
Meropenem
3
Ceftazidime
3
Filgrastim
2
Ciprofloxacin
2
Cefepime
2
ceftolozane, tazobactam drug combination
1
Vancomycin
1
Teicoplanin
1
Simvastatin
1
Positron Emission Tomography Computed Tomography
1
Ofloxacin
1
NF protocol
1
Micafungin
1
Metronidazole
1
Levofloxacin
1
Itraconazole
1
Granulocyte Colony-Stimulating Factor
1
Cilastatin, Imipenem Drug Combination
1
Anti-Bacterial Agents
1
Amikacin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Febrile Neutropenia
×
ceftolozane, tazobactam drug combination
×
Other hematologic neoplasm
×
Clear all
NCT05061654
2023-08-14
CEF-10
Hamad Medical Corporation
Phase 4
Withdrawn